[1]
E. F. Moya Ayre and I. Bermúdez Maldonado, “Adalimumab, therapeutic alternative in the Vogt Koyanagi Harada syndrome refractory to infliximab: case report”, An Fac med, vol. 77, no. 1, pp. 55–58, Mar. 2016, doi: 10.15381/anales.v77i1.11554.